Quick Answer
FEMASYS INC reported Research And Development Expense of $7.58 million for the year ending 2025.
- FEMASYS INC showed a decrease of -7.8% in Research And Development Expense from 2024 to 2025.
- This data is from FEMASYS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $888.7 thousand | Q3 2020: $995.6 thousand | Q1 2021: $995.0 thousand | Q2 2021: $894.9 thousand | Q3 2021: $1.14 million | Q1 2022: $1.42 million | Q2 2022: $1.47 million | Q3 2022: $1.65 million | Q1 2023: $1.54 million | Q2 2023: $1.53 million | Q3 2023: $2.07 million | Q1 2024: $1.77 million | Q2 2024: $1.98 million | Q3 2024: $2.30 million | Q1 2025: $2.97 million | Q2 2025: $1.41 million | Q3 2025: $1.38 million.
- Over the full 6 years of available data (2020 to 2025), FEMASYS INC's Research And Development Expense has grown by 83.5%.
- Historical annual values: Fiscal year 2025: $7.58 million | Fiscal year 2024: $8.22 million | Fiscal year 2023: $7.21 million | Fiscal year 2022: $5.81 million | Fiscal year 2021: $4.08 million | Fiscal year 2020: $4.13 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: